EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS-261622005

$0N01FY2006CMNIH

Mayo Clinic Rochester /Inc/

Investigators

Charles Erlichmancontact

View original record on NIH RePORTER →